{"name":"National Center for AIDS/STD Control and Prevention, China CDC","slug":"national-center-for-aids-std-control-and-prevention-china-cdc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Regimen:TDF+3TC+EFV","genericName":"Regimen:TDF+3TC+EFV","slug":"regimen-tdf-3tc-efv","indication":"HIV-1 infection (treatment)","status":"marketed"},{"name":"Regimen：BIC+FTC+TAF","genericName":"Regimen：BIC+FTC+TAF","slug":"regimen-bic-ftc-taf","indication":"HIV-1 infection in treatment-naïve and treatment-experienced adults","status":"marketed"}]}],"pipeline":[{"name":"Regimen:TDF+3TC+EFV","genericName":"Regimen:TDF+3TC+EFV","slug":"regimen-tdf-3tc-efv","phase":"marketed","mechanism":"This combination regimen inhibits HIV reverse transcriptase and integrase through three antiretroviral agents, preventing viral replication and reducing viral load.","indications":["HIV-1 infection (treatment)"],"catalyst":""},{"name":"Regimen：BIC+FTC+TAF","genericName":"Regimen：BIC+FTC+TAF","slug":"regimen-bic-ftc-taf","phase":"marketed","mechanism":"This combination regimen inhibits HIV reverse transcriptase and integrase to suppress viral replication and prevent AIDS progression.","indications":["HIV-1 infection in treatment-naïve and treatment-experienced adults","HIV-1 infection in adolescents and children (weight-based dosing)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5wODhnYklWZ0lQcVNzY1pDMU5GNzR2Q21qSmpNM1hrc1RyODdVMndLUklZSVlFWThVUi0ybVVCb01mWGx1M29CSzNHYy1PT0IyNlc2SnpXSUhkRjlEa1RF?oc=5","date":"2025-12-24","type":"trial","source":"Nature","summary":"Urine-based HIV-1 self-testing in China: A cross-sectional diagnostic accuracy and usability study - Nature","headline":"Urine-based HIV-1 self-testing in China: A cross-sectional diagnostic accuracy and usability study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOenBRTnBLNlhFZGd5eHk2N25RZHJ2QUM0LVJVTlo4UzQ2V0toeXNvRFU3a2VESF9yME9JVnNMbHhkZ0h3Q1VsRXh0eWJtYjJibEhvR1g3bFI2S2RaOFR6TFRILTRfQWdLdk1xUVpsQURxdTE0WTBaVzRWX0JkNkkzdXZaZDM4ZjVfcnlPZ0Y1dnQ3Q2c3Wnc?oc=5","date":"2025-09-26","type":"pipeline","source":"Frontiers","summary":"Alcohol consumption patterns and risk of HIV transmission among men who have sex with men living with HIV in Chongqing, southwestern China - Frontiers","headline":"Alcohol consumption patterns and risk of HIV transmission among men who have sex with men living with HIV in Chongqing, ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1Qbmc3eWdzVDV5V0xYa3hGal9YdDhUV0JXSEpvVXFNb2Npdlg2Vks5MXBYRjZ2VmtqSGVxY3piMFRZYXNvRi1GM0JwMVk3UkJm?oc=5","date":"2025-08-26","type":"pipeline","source":"gh.bmj.com","summary":"Mpox containment strategies in China, 2022–2023: from preparedness to legal management - gh.bmj.com","headline":"Mpox containment strategies in China, 2022–2023: from preparedness to legal management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiW0FVX3lxTE10bUpkSzMzLXItOWlGdnJXMW1yQUliMUV5cUp0WE1zSUk0MWdaZ3lzMG4xVmF3MGZoV0hqSDVscllqc3IxN1prQTZUVnJXYUY4cDFfX2k0ZmNCSDg?oc=5","date":"2024-12-05","type":"pipeline","source":"Centers for Disease Control and Prevention | CDC (.gov)","summary":"Doxy PEP for Bacterial STI Prevention - Centers for Disease Control and Prevention | CDC (.gov)","headline":"Doxy PEP for Bacterial STI Prevention - Centers for Disease Control and Prevention | CDC (.gov)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9GRlZXNThRR3pvSlQyWHBvRjdIX0x2RENBVFJxVzA3NFFPOFJubE1ERmUzR1RSUURfRDRFczdMbmV5ZndGVTgzREJTd19LbTdjYkhPaHR4SmJPQlduNXdndGRQd0VWaTFoTV9renA5d2E3OUwteE9LWA?oc=5","date":"2024-10-17","type":"pipeline","source":"Psychiatry Online","summary":"Psychiatric Manifestations as Primary Symptom of Neurosyphilis Among HIV-Negative Patients - Psychiatry Online","headline":"Psychiatric Manifestations as Primary Symptom of Neurosyphilis Among HIV-Negative Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxNQXBDUFg3bk1zVVhJbFhXV2lsZnhDLVowdXJLNHMwenhjRFNkREw5YWdmdDdmMnVqdHBJMG1mQW5vOHhrWnJJUmpYTG5VczBXcklvckU4OERxN091TkFRbVhJTEJZYmtVem1BWFhvUFpEN0JwWnJkSXlWd25xSXFWdHBIVDZodk5jaXZNZmFERnliNTQy?oc=5","date":"2024-02-15","type":"pipeline","source":"Frontiers","summary":"The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China - Frontiers","headline":"The Epidemic of Sexually Transmitted Diseases Under the Influence of COVID-19 in China","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNVG5zWmNKcEt5RzJpMUxqR3B3TkJZbHdQX3lXWDZWVUhMOEpNY01TVU9nM3dsQWYxbnZkNFB2M2lQSHVMN1VMQ0d0MFdlN0RaSHlxbDZzWlRoWS1ralBXeHo4SDEyRUM5dTlYNzVFc3Z2eTJhN0lNYmN6cW9MX3d1UHo4NXJDcEFEaXJISHdZdjAxdkxuWlE?oc=5","date":"2023-08-09","type":"pipeline","source":"statnews.com","summary":"CDC director overhauls leadership of center that oversaw response to Covid-19 - statnews.com","headline":"CDC director overhauls leadership of center that oversaw response to Covid-19","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQRDJWY3BydXR3OVhRS0U3bmhWRmxTV29hM3FRUVBvYkgyTGV0LTcyT3BhZ1B3X2RqeGVPbWpMbDJ0bmN5d0NlTU5URDF5NFc5aUk3emJGSXlwY2ctT0hmOTBUVERKS0tjYS1odlpDdlREeF90cVczTEVvTUF6Sk9fOTVuSjN3R0prOXIwS0xTUzduR25oUG9Qay1jUzBBYU5WTkJBYkxjNU5yVGdnV1BSajdVRQ?oc=5","date":"2022-12-02","type":"pipeline","source":"Gates Foundation","summary":"Advancing global health innovation, equity, and accessibility - Gates Foundation","headline":"Advancing global health innovation, equity, and accessibility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE1KRTY5M0tiQ1JScGd6blIwUDB1bjZUanpPYThqc2RNN3RVc3pvMTNya1lnTFlPdVZqOHRsaUZFeXdZT214ZGoyOFlWTHJkZWYwVVpROWwwM1Ywaml2bTlrX09zVmJWZkVzTGhXUXBWUTNZMzlXRktpYg?oc=5","date":"2018-08-28","type":"pipeline","source":"CNN","summary":"STD rates in US reach record high, CDC says - CNN","headline":"STD rates in US reach record high, CDC says","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxNUDU0UmR1WWxEWHNEQW9WN2NVZE1GQVI2cnh2cVFrSHZEUlE5VUk1WW94V0ZJSDlXLU9qckJWa19zV1ZQc294YjBYSkdqTkd4SEprOUxaOHFER2NCZEVFeHFqd3ZVOUhrMldQNjVUVkhyX2F4T2VMU05kZzVzS3owOFRFUU03NV9Ya2FENXhOUU1CMFd1UFI3T0dtcTBRMkxINTRuWmU5SFBra3owUkh0VU5SbzI?oc=5","date":"2018-03-06","type":"pipeline","source":"HIV.gov","summary":"HIV Prevention Pill not Reaching Most Americans Who Could Benefit – Especially People of Color - HIV.gov","headline":"HIV Prevention Pill not Reaching Most Americans Who Could Benefit – Especially People of Color","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxQak1IV0VLc2w2eU1rMWdNcUpjMktxTVVuOW9jeGRpM0ZVUVhfT1VYcEpaeE5WMkJLTDJYWDg4eXlQRHB4NzRTWWxydDN5V0xKZHl4OEZmYjN4WEg4RHV6dTRBQW12SG94X3FMeDNEMmhwOUZOdXBieG42QVZ4XzkySGdOUjMwdw?oc=5","date":"2017-06-13","type":"pipeline","source":"The Lancet","summary":"Evolution of China's response to HIV/AIDS - The Lancet","headline":"Evolution of China's response to HIV/AIDS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTFBmVzZqR0xBOWFWUi1aODNDdjZ0UjN6RHFueUNFY010bWZ1QUxwMUU5Nzl2cHRlM25qcGd4bGdyOERJZmxsbFVNang0VTZGMk16Z2ZBUlZGVW13LXJVLVE?oc=5","date":"2007-05-03","type":"pipeline","source":"NEJM","summary":"China and HIV — A Window of Opportunity - NEJM","headline":"China and HIV — A Window of Opportunity","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"marketed":2},"enrichmentLevel":0,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}